Dear Colleagues,

There are big changes afoot for OIP-ISR at UCLA. In August 2011, Distinguished Professor Bill Ouchi of the UCLA Anderson School of Management put forward the recommendation that the Office of Intellectual Property and Industry Sponsored Research (OIP-ISR) be overseen by an independent 501 (c)(3) entity with an external Board of Directors. On May 16th, the Regents of the University of California granted their unanimous approval of this proposal – a first for the University of California system.

This means that we will have a board of experienced executives – with background in industry, venture capital, and technology licensing – to advise on industry relationships and the advancement of UCLA research for the benefit of society.

While our staff remain a part of UCLA, this change brings great promise and a new wealth of experience to OIP-ISR. In addition to the Board, which remains to be selected, we have launched an  Entrepreneur-In-Residence program with four experienced executives who have committed to volunteer their time to advise aspiring entrepreneurs on the UCLA campus.

We look forward to working with you, and leveraging the experience these new resources will bring to OIP-ISR.

Sincerely,

Brendan Rauw 
Associate Vice Chancellor and Executive Director of Entrepreneurship .

~~~~~

OIP offers new programs and opportunities geared toward faculty and student entrepreneurs.

It dawned on him during a train ride from Mountain View, Calif. and developed into a full-fledged business plan by the time the train pulled into San Francisco 45 minutes later.

Self-described serial entrepreneur and UCLA alumnus Jun Loayza has used ideas – like the one he and his friend Stephen Johnson, also a UCLA alumnus who interned at Loayza’s first start up and later became his business partner, stumbled upon during the train ride three years ago – to create seven companies in the past six years.

Out of his seven companies, which include social media applications, Loayza said four of the projects were successful. One of his projects, Lionstep Media has worked on campaigns for Sephora and Whole Foods.

But entrepreneurship is not as simple as just thinking of a good idea...

[ Read Full Article ]

~~~~~

UCLA Licensee, Kite Pharma Inc., Completes $35 Million Financing Round
Funding to Support Clinical and Manufacturing Activities of Novel Cancer Immunotherapuetics.

~~~~~

Licensed Technology Platform Includes Three Pending Patent Applications.

Quest PharmaTech Inc., a pharmaceutical company developing and commercializing products for the treatment of cancer, announces that it has recently signed an exclusive license agreement with University of California at Los Angeles to develop and market anti-PSA IgE technology for the treatment of cancer.

The technology was developed by Professor Manuel Penichet and Dr. Tracy Daniels-Wells in collaboration with Dr. Christopher Nicodemus among others. It covers the use of immunotherapeutic IgE in development for treatment of patients with malignancies expressing the tumor-associated antigen PSA, which is associated with prostate cancer.

[ Read Full Press Release ]
[ Quest PharmaTech ]

~~~~~

[ RSVP ]

[ Info & Registration  ]

• UCLA Research Expertise

• Submit a New Invention Report

• OIP-ISR Team

• BRUIN - Entrepreneurial Support Network

• Startup UCLA

• Business of Science

• Accelerators and Incubators on the Westside